Enantone
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
482 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Prostatic neoplasms | D011471 | — | C61 | 27 | 126 | 69 | 12 | 31 | 250 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 3 | 23 | 20 | 2 | 7 | 52 |
| Endometriosis | D004715 | EFO_0001065 | N80 | 1 | 8 | 5 | 4 | 7 | 25 |
| Precocious puberty | D011629 | — | E22.8 | 2 | — | 7 | 9 | 4 | 22 |
| Infertility | D007246 | EFO_0000545 | — | 3 | — | 2 | 6 | 7 | 18 |
| Recurrence | D012008 | — | — | — | 5 | 6 | 1 | 1 | 13 |
| Leiomyoma | D007889 | — | D25 | 1 | 3 | 4 | 4 | 2 | 13 |
| Myofibroma | D047708 | — | — | 1 | 3 | 4 | 2 | 2 | 11 |
| Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | 1 | 1 | — | 3 | 3 | 8 |
| Syndrome | D013577 | — | — | 1 | 1 | — | 2 | 2 | 6 |
Show 31 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Adenocarcinoma | D000230 | — | — | 3 | 22 | 8 | — | 3 | 34 |
| Carcinoma | D002277 | — | C80.0 | 2 | 7 | 2 | — | 1 | 12 |
| Neoplasms | D009369 | — | C80 | — | 6 | 3 | — | 1 | 10 |
| Obesity | D009765 | EFO_0001073 | E66.9 | 2 | — | 1 | — | 5 | 8 |
| Castration-resistant prostatic neoplasms | D064129 | — | — | 2 | 4 | 2 | — | — | 7 |
| Male breast neoplasms | D018567 | — | — | 1 | 1 | 3 | — | 1 | 5 |
| Female infertility | D007247 | EFO_0008560 | N97 | 1 | — | 1 | — | 2 | 4 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | — | 3 | 1 | — | — | 4 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | — | 2 | 1 | — | — | 3 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | 1 | — | 1 | 2 |
Show 23 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypersensitivity | D006967 | EFO_0003785 | T78.40 | 2 | 7 | — | — | 1 | 10 |
| Hypogonadism | D007006 | — | E23.0 | — | 2 | — | — | 3 | 5 |
| Salivary gland neoplasms | D012468 | EFO_0003826 | D11 | — | 3 | — | — | 1 | 4 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | — | 3 | — | — | — | 3 |
| Multiple myeloma | D009101 | — | C90.0 | — | 3 | — | — | — | 3 |
| Healthy volunteers/patients | — | — | — | 3 | 1 | — | — | — | 3 |
| Primary ovarian insufficiency | D016649 | EFO_0004266 | E28.3 | — | 1 | — | — | 2 | 3 |
| Premature menopause | D008594 | — | E28.31 | — | 1 | — | — | 2 | 3 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | 3 | — | — | — | 3 |
| Hyperandrogenism | D017588 | — | — | 1 | 1 | — | — | — | 2 |
Show 45 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Overweight | D050177 | — | E66.3 | 1 | — | — | — | — | 1 |
| Antibiotic prophylaxis | D019072 | — | — | 1 | — | — | — | — | 1 |
| Transgenes | D019076 | — | — | 1 | — | — | — | — | 1 |
| Postmenopausal osteoporosis | D015663 | EFO_0003854 | — | 1 | — | — | — | — | 1 |
| Delayed puberty | D011628 | — | E30.0 | 1 | — | — | — | — | 1 |
| Menstruation disturbances | D008599 | — | N91.5 | 1 | — | — | — | — | 1 |
| Premenstrual syndrome | D011293 | — | N94.3 | 1 | — | — | — | — | 1 |
| Paraphilic disorders | D010262 | — | F65 | 1 | — | — | — | — | 1 |
| Postoperative pain | D010149 | — | G89.18 | 1 | — | — | — | — | 1 |
| Embryo transfer | D004624 | — | — | 1 | — | — | — | — | 1 |
Show 1 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Gender dysphoria | D000068116 | — | F64 | — | — | — | — | 2 | 2 |
| Endocrine system diseases | D004700 | EFO_0001379 | E34.9 | — | — | — | — | 1 | 1 |
| Adiposity | D050154 | — | — | — | — | — | — | 1 | 1 |
| Embryo implantation | D010064 | — | — | — | — | — | — | 1 | 1 |
| Executive function | D056344 | — | — | — | — | — | — | 1 | 1 |
| Coronary disease | D003327 | — | — | — | — | — | — | 1 | 1 |
| Coronary artery disease | D003324 | — | I25.1 | — | — | — | — | 1 | 1 |
| Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | — | — | 1 | 1 |
| Heart diseases | D006331 | EFO_0003777 | I51.9 | — | — | — | — | 1 | 1 |
| Microbiota | D064307 | — | — | — | — | — | — | 1 | 1 |
Show 12 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1,398 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use